The Zacks Analyst Blog Highlights:Apple, Google, Hewlett-Packard, Microsoft and Ocwen Financial - KAUZ-TV: Newschannel 6 Now | Wichita Falls, TX

The Zacks Analyst Blog Highlights:Apple, Google, Hewlett-Packard, Microsoft and Ocwen Financial

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Zacks Investment Research, Inc.

CHICAGO, Feb. 21, 2014 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Apple (Nasdaq:AAPL-Free Report), Google (Nasdaq:GOOG-Free Report), Hewlett-Packard (NYSE:HPQ-Free Report), Microsoft (Nasdaq:MSFT-Free Report) and Ocwen Financial Corp. (NYSE:OCN-Free Report)

(Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO)

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

Here are highlights from Thursday's Analyst Blog:

Apple Working on a Mobile Medical Device?

Reportedly, Apple (Nasdaq:AAPL-Free Report) is working on a technology that will be able to warn about a heart attack based on the sound of blood flowing through the arteries. This sensor could well be part of Apple's wearable device, referred to as iWatch and will monitor both heart beat and blood oxygen level.

The device will alert users and thus a heart attack can be prevented with timely medical intervention. As per Verge, Apple is collaborating with audio engineer Tomlinson Holman to develop the heart attack predicting device.

As per reports, Apple will use optoelectronics to monitor the user's body glucose levels. Optoelectronics makes good usage of the light passing through the body as a non-invasive means of regulating health.

Last month, The New York Times reported that Apple has had discussions with the Food and Drug Administration regarding mobile medical applications. Although this further added fuel to the ongoing rumors, there has been no official confirmation from Apple on the latest development of the wearable device.

The iWatch will help Apple to step into the world of wearable devices following the footsteps of its competitor Google (Nasdaq:GOOG-Free Report).

We believe that Apple's intention to extend its foothold into new product categories such as healthcare and cars in the near term will drive growth and profitability going forward.

Apple's loyal customer base, international expansion, competitive pricing strategy and a solid cash position will aid long-term growth. However, increasing competition from the likes of Google,Hewlett-Packard (NYSE:HPQ-Free Report), Microsoft (Nasdaq:MSFT-Free Report) in most of its major product segments, possible delays in product launch, higher operating expenses and increasing legal complexities  are headwinds.

Currently, Apple has a Zacks Rank #3 (Hold).

Ocwen Floats MSR-Backed Bonds

In a deviation to Ocwen Financial Corp.'s (NYSE:OCN-Free Report) usual method of driving growth by aggressive acquisition of mortgage servicing rights (MSRs), the company has launched a bond deal backed by MSRs instead. The news was confirmed by a report in the Financial Times.

The deal named "oasis" is the first of its kind in Ocwen's history and is worth $136 million. Moreover, it will primarily target investors seeking fixed income.

Now here lies our major concern as most MSRs related to the aforementioned bond are tied to subprime assets. The targeted fixed income investors group usually avoids risky ventures with lower credit ratings. Hence, we are not that confident about the success of the aforementioned deal.

Nevertheless, we observe that there has been an improvement in the subprime market and investors are gaining confidence. Therefore, Ocwen could benefit if the market continues to stabilize at the same pace.  

On the other hand, of late the situation is turning out to be sticky for Ocwen. As per a recent Financial Times report, investors are contemplating on filing a lawsuit against Ocwen over its mortgage servicing practices and loan modifications.

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today.

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros.  In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros.

Get the full Report on AAPL - FREE

Get the full Report on GOOG - FREE

Get the full Report on HPQ - FREE

Get the full Report on MSFT - FREE

Get the full Report on OCN - FREE

Follow us on Twitter: http://twitter.com/zacksresearch

Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
http://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.


 

 

©2012 PR Newswire. All Rights Reserved.